Assessment of multimodality therapy use for extremity sarcoma in the United States.
about
Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis.Older age impacts radiotherapy-related outcomes in soft tissue sarcoma.Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience.The role of modern radiation therapy in the management of extremity sarcomas.Angiosarcoma: A rare malignancy with protean clinical presentations.Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.The role of margins in extremity soft tissue sarcoma.Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions.Preoperative vs postoperative radiation therapy in localized soft tissue sarcoma: Nationwide patterns of care and trends in utilization.An unresectable retroperitoneal malignant fibrous histiocytoma: A case report.The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.Quality of life, functional outcomes, and wound complications in patients with soft tissue sarcomas treated with preoperative chemoradiation: a prospective study.Pleomorphic liposarcoma: An analysis of 6 case reports and literature review.Primary Pleomorphic Liposarcoma of Fallopian Tube with Recurrence: A Case Report and Review of the Literature.Giant paratesticular liposarcoma: A case report and review of the literature.Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunction.CORR Insights: Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
P2860
Q34664193-7457A130-F2AD-4D92-90BE-0EFB6CD80A7DQ36680534-BEC1D6CF-9EEE-4157-A96D-F18FFBDC229EQ37055482-6F4E116B-1951-49DC-B756-BBD758FC5A0CQ37693433-C1483248-DA98-4CEC-8462-F0B817361169Q38264730-D7F74EB8-F52D-4D4E-A903-425DD71C2DEDQ38510830-3FDB27DC-D6E6-48ED-899C-E45469E5B39CQ38663094-0D2A8548-4BEC-4A8A-BFA8-1DCF977C8191Q38668085-57EBBE35-C50C-4E3E-BFA4-E8319FFB781CQ38707594-DC24BCDB-CD65-448E-BCCA-4E800E5BBFF7Q38760037-1E210FB9-7AB8-4D92-96C8-E62F259A381AQ39644087-D43BAA08-E768-466C-83A2-DADB4B8D4216Q40051797-D3AC2495-5604-47D8-B5FB-1A2D71D4BAE3Q46330226-312FA922-79EB-41EF-8845-5B9BF32A5834Q48045483-B5E2F9C9-3865-4581-9CDE-BB0DE3521AD7Q49711860-C42E1AD8-4D62-4201-805A-64D7BF6737E9Q52697251-3B19A29C-F07A-4BA7-B2A9-27F8F58A3D45Q55239829-CBF3FCC8-9134-46D7-8618-D904E4B41308Q55690001-DDA53A21-8AE6-4E5B-B34A-6F95C5BAA70CQ58814145-AD44A9D3-E7D2-4B69-819A-3AF256B9663D
P2860
Assessment of multimodality therapy use for extremity sarcoma in the United States.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@ast
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@en
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@nl
type
label
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@ast
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@en
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@nl
prefLabel
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@ast
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@en
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@nl
P2093
P2860
P356
P1476
Assessment of multimodality therapy use for extremity sarcoma in the United States.
@en
P2093
David J Bentrem
Jeanette Chung
Jeffrey D Wayne
John P Hayes
Karen L Sherman
Karl Y Bilimoria
Mark Agulnik
Raphael E Pollock
Samer Attar
Terrance D Peabody
P2860
P304
P356
10.1002/JSO.23520
P577
2013-12-20T00:00:00Z